{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:29:42Z","timestamp":1789684182158,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.4158\/ep.12.4.427","type":"journal-article","created":{"date-parts":[[2013,4,8]],"date-time":"2013-04-08T21:04:54Z","timestamp":1365455094000},"page":"427-431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Thyrotoxic Periodic Paralysis in A Hispanic Man after the Administration Of Prednisone"],"prefix":"10.1016","volume":"12","author":[{"given":"Zhao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis E.","family":"Braverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Malabanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP.12.4.427_bb0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00005792-199205000-00001","article-title":"Thyrotoxic periodic paralysis in the United States: report of 7 cases and review of the literature","volume":"71","author":"Ober","year":"1992","journal-title":"Medicine (Baltimore)."},{"key":"10.4158\/EP.12.4.427_bb0010","first-page":"11","article-title":"Thyrotoxic hypokalemic periodic paralysis: report of four cases and review of the literature: (1) and (2)","volume":"80","author":"Tinker","year":"1987","journal-title":"J Okla State Med Assoc."},{"key":"10.4158\/EP.12.4.427_bb0015","doi-asserted-by":"crossref","first-page":"332","DOI":"10.7326\/0003-4819-81-3-332","article-title":"Thyrotoxicosis and periodic paralysis: improvement with beta blockade","volume":"81","author":"Conway","year":"1974","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.12.4.427_bb0020","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/pgmj.57.666.238","article-title":"Potassium shift in thyrotoxic periodic paralysis","volume":"57","author":"Feely","year":"1981","journal-title":"Postgrad Med J."},{"key":"10.4158\/EP.12.4.427_bb0025","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0002-9343(74)90010-2","article-title":"Thyrotoxic periodic paralysis: effect of propranolol","volume":"57","author":"Yeung","year":"1974","journal-title":"Am J Med."},{"key":"10.4158\/EP.12.4.427_bb0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/thy.1999.9.61","article-title":"Normokalemic thyrotoxic periodic paralysis: a new therapeutic strategy","volume":"9","author":"Gonzalez-Trevino","year":"1999","journal-title":"Thyroid."},{"key":"10.4158\/EP.12.4.427_bb0035","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0300-2977(96)00014-9","article-title":"Hypokalemic thyrotoxic periodic paralysis: case report and review of an Oriental syndrome","volume":"49","author":"van Dam","year":"1996","journal-title":"Neth J Med."},{"key":"10.4158\/EP.12.4.427_bb0040","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1001\/archinte.1989.00390110139031","article-title":"Thyrotoxic periodic paralysis: report of 10 cases and review of electromyographic findings","volume":"149","author":"Kelley","year":"1989","journal-title":"Arch Intern Med."},{"key":"10.4158\/EP.12.4.427_bb0045","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1210\/jcem-17-12-1454","article-title":"The association of periodic paralysis and hyperthyroidism in Japan","volume":"17","author":"Okinaka","year":"1957","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.12.4.427_bb0050","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/bmj.1.5538.451","article-title":"Periodic paralysis complicating thyrotoxicosis in Chinese","volume":"1","author":"McFadzean","year":"1967","journal-title":"Br Med J."},{"key":"10.4158\/EP.12.4.427_bb0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jemermed.2003.05.004","article-title":"The pitfalls of potassium replacement in thyrotoxic periodic paralysis: a case report and review of the literature","volume":"26","author":"Tassone","year":"2004","journal-title":"J Emerg Med."},{"key":"10.4158\/EP.12.4.427_bb0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0025-6196(11)62965-0","article-title":"Thyrotoxic periodic paralysis","volume":"80","author":"Lin","year":"2005","journal-title":"Mayo Clin Proc."},{"key":"10.4158\/EP.12.4.427_bb0065","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ana.410110602","article-title":"Periodic paralysis and the sodium-potassium pump","volume":"11","author":"Layzer","year":"1982","journal-title":"Ann Neurol."},{"key":"10.4158\/EP.12.4.427_bb0070","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archinte.159.6.601","article-title":"Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes","volume":"159","author":"Manoukian","year":"1999","journal-title":"Arch Intern Med."},{"key":"10.4158\/EP.12.4.427_bb0075","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1001\/archinte.1982.00340200130024","article-title":"Thyrotoxic periodic paralysis with ventricular fibrillation","volume":"142","author":"Fisher","year":"1982","journal-title":"Arch Intern Med."},{"key":"10.4158\/EP.12.4.427_bb0080","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1210\/jc.2002-020698","article-title":"A mutation in the KCNE3 potassium channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis","volume":"87","author":"Dias da Silva","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.12.4.427_bb0085","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1515\/JPEM.2004.17.12.1679","article-title":"Thyrotoxic periodic paralysis associated with a mutation in the sodium channel gene SCN4A","volume":"17","author":"Lane","year":"2004","journal-title":"J Pediatr Endocrinol Metab."},{"key":"10.4158\/EP.12.4.427_bb0090","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00000441-200502000-00003","article-title":"Skeletal muscle dihydropyridine-sensitive calcium channel (CACNA1S) gene mutations in Chinese patients with hypokalemic periodic paralysis","volume":"329","author":"Lin","year":"2005","journal-title":"Am J Med Sci."},{"key":"10.4158\/EP.12.4.427_bb0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2265.2004.02079.x","article-title":"No mutation in the KCNE3 potassium channel gene in Chinese thyrotoxic hypokalaemic periodic paralysis patients","volume":"61","author":"Tang","year":"2004","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP.12.4.427_bb0100","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/105072504773297858","article-title":"Absence of ion channels CACN1AS and SCN4A mutations in thyrotoxic hypokalemic periodic paralysis","volume":"14","author":"Ng","year":"2004","journal-title":"Thyroid."},{"key":"10.4158\/EP.12.4.427_bb0105","first-page":"139","article-title":"Manifestation, management and molecular analysis of candidate genes in two rare cases of thyrotoxic hypokalemic periodic paralysis","volume":"63","author":"Schalin-Jantti","year":"2005","journal-title":"Horm Res."},{"key":"10.4158\/EP.12.4.427_bb0110","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1365-2265.2002.01481.x","article-title":"Mutations linked to familial hypokalaemic periodic paralysis in the calcium channel alpha1 subunit gene (Cav1.1) are not associated with thyrotoxic hypokalaemic periodic paralysis","volume":"56","author":"Dias da Silva","year":"2002","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP.12.4.427_bb0115","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1210\/jc.2003-030924","article-title":"Association of novel single nucleotide polymorphisms in the calcium channel alpha 1 subunit gene (Ca(v)1.1) and thyrotoxic periodic paralysis","volume":"89","author":"Kung","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.12.4.427_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1989.1","article-title":"Regulation of the Na, K-pump in skeletal muscle","volume":"35","author":"Clausen","year":"1989","journal-title":"Kidney Int."},{"key":"10.4158\/EP.12.4.427_bb0125","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1152\/physrev.00011.2003","article-title":"Na+-K+ pump regulation and skeletal muscle contractility","volume":"83","author":"Clausen","year":"2003","journal-title":"Physiol Rev."},{"key":"10.4158\/EP.12.4.427_bb0130","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00063110-200309000-00012","article-title":"The administration of beta2-agonists for paediatric asthma and its adverse reaction in Australian and New Zealand emergency departments: a cross-sectional survey","volume":"10","author":"Habashy","year":"2003","journal-title":"Eur J Emerg Med."},{"key":"10.4158\/EP.12.4.427_bb0135","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1378\/chest.110.3.595","article-title":"Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma","volume":"110","author":"Newhouse","year":"1996","journal-title":"Chest."},{"key":"10.4158\/EP.12.4.427_bb0140","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00006565-199804000-00015","article-title":"Hypokalemia in an asthmatic child from abuse of albuterol metered dose inhaler","volume":"14","author":"Rakhmanina","year":"1998","journal-title":"Pediatr Emerg Care."},{"key":"10.4158\/EP.12.4.427_bb0145","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.1016\/S0021-9258(18)42725-1","article-title":"Insulin induces translocation of the alpha 2 and beta 1 subunits of the Na+\/K(+)-ATPase from intracellular compartments to the plasma membrane in mammalian skeletal muscle","volume":"267","author":"Hundal","year":"1992","journal-title":"J Biol Chem."},{"key":"10.4158\/EP.12.4.427_bb0150","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0736-4679(99)00194-8","article-title":"Thyrotoxic periodic paralysis and intravenous propranolol in the emergency setting","volume":"18","author":"Birkhahn","year":"2000","journal-title":"J Emerg Med."},{"key":"10.4158\/EP.12.4.427_bb0155","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0196-0644(94)70286-1","article-title":"Thyrotoxic periodic paralysis terminated with intravenous propranolol","volume":"24","author":"Shayne","year":"1994","journal-title":"Ann Emerg Med."},{"key":"10.4158\/EP.12.4.427_bb0160","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1345\/aph.1C095","article-title":"Steroid-induced myopathy in the ICU","volume":"36","author":"Polsonetti","year":"2002","journal-title":"Ann Pharmacother."},{"key":"10.4158\/EP.12.4.427_bb0165","first-page":"963","article-title":"Cortisol inactivation overload: a mechanism of mineralo-corticoid hypertension in the ectopic adrenocorticotropin syndrome","volume":"74","author":"Ulick","year":"1992","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.12.4.427_bb0170","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.2002.tb04419.x","article-title":"Association of hypertension and hypokalemia with Cushing\u2019s syndrome caused by ectopic ACTH secretion: a series of 58 cases","volume":"970","author":"Torpy","year":"2002","journal-title":"Ann N Y Acad Sci."},{"key":"10.4158\/EP.12.4.427_bb0175","doi-asserted-by":"crossref","first-page":"C509","DOI":"10.1152\/ajpcell.2001.280.3.C509","article-title":"D0rup I, Ahn J, Leong PK, McDonough AA. Glucocorticoids increase sodium pump alpha(2)- and beta(1)-subunit abundance and mRNA in rat skeletal muscle","volume":"280","author":"Thompson","year":"2001","journal-title":"Am J Physiol Cell Physiol."},{"key":"10.4158\/EP.12.4.427_bb0180","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1053\/meta.2002.35199","article-title":"Magnesium, sodium, and potassium content and [3H]ouabain binding capacity of skeletal muscle in relatives of patients with type 2 diabetes: effect of dexamethasone","volume":"51","author":"Djurhuus","year":"2002","journal-title":"Metabolism."},{"key":"10.4158\/EP.12.4.427_bb0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2796.1997.69891000.x","article-title":"D0rup I. The concentration of sodium, potassium pumps in chronic obstructive lung disease (COLD) patients: the impact of magnesium depletion and steroid treatment","volume":"241","author":"Ravn","year":"1997","journal-title":"J Intern Med."},{"key":"10.4158\/EP.12.4.427_bb0190","doi-asserted-by":"crossref","first-page":"L593","DOI":"10.1152\/ajplung.00037.2003","article-title":"Dexamethasone stimulates transcription of the Na+-K+-ATPase beta1 gene in adult rat lung epithelial cells","volume":"285","author":"Hao","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"10.4158\/EP.12.4.427_bb0195","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1172\/JCI119175","article-title":"Direct glucocorti-coid inhibition of insulin secretion: an in vitro study of dexamethasone effects in mouse islets","volume":"99","author":"Lambillotte","year":"1997","journal-title":"J Clin Invest."},{"key":"10.4158\/EP.12.4.427_bb0200","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0168-8227(00)00229-1","article-title":"The effects of dexamethasone on insulin release and biosynthesis are dependent on the dose and duration of treatment","volume":"51","author":"Jeong","year":"2001","journal-title":"Diabetes Res Clin Pract."},{"key":"10.4158\/EP.12.4.427_bb0205","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s001250050961","article-title":"Increased glucocor-ticoid sensitivity in islet beta-cells: effects on glucose-6-phosphatase, glucose cycling and insulin release","volume":"41","author":"Ling","year":"1998","journal-title":"Diabetologia."},{"key":"10.4158\/EP.12.4.427_bb0210","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2337\/diab.40.12.1701","article-title":"Islet amyloid polypeptide and insulin secretion from isolated perfused pancreas of fed, fasted, glucose-treated, and dexamethasone-treated rats","volume":"40","author":"O\u2019Brien","year":"1991","journal-title":"Diabetes."},{"key":"10.4158\/EP.12.4.427_bb0215","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1172\/JCI115886","article-title":"Roles of insulin resistance and beta-cell dysfunction in dexamethasone-induced diabetes","volume":"90","author":"Ogawa","year":"1992","journal-title":"J Clin Invest."},{"key":"10.4158\/EP.12.4.427_bb0220","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1055\/s-0028-1093528","article-title":"On the role of glucocorticoid in glucose-induced insulin secretion","volume":"9","author":"Kawai","year":"1997","journal-title":"Horm Metab Res."},{"key":"10.4158\/EP.12.4.427_bb0225","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s125-002-8244-y","article-title":"Glucocorticoid induced insulin resistance impairs basal but not glucose entrained high-frequency insulin pulsatility in humans","volume":"45","author":"Hollingdal","year":"2002","journal-title":"Diabetologia."},{"key":"10.4158\/EP.12.4.427_bb0230","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1262-3636(07)70123-4","article-title":"Dexamethasone-induced insulin resistance shows no gender difference in healthy humans","volume":"30","author":"Binnert","year":"2004","journal-title":"Diabetes Metab."},{"key":"10.4158\/EP.12.4.427_bb0235","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1055\/s-2007-979015","article-title":"Predictors of change in insulin sensitivity during gluco-corticoid treatment","volume":"29","author":"Meacham","year":"1997","journal-title":"Horm Metab Res."},{"key":"10.4158\/EP.12.4.427_bb0240","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF00399099","article-title":"Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans","volume":"36","author":"Ludvik","year":"1993","journal-title":"Diabetologia."},{"key":"10.4158\/EP.12.4.427_bb0245","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0026-0495(96)90224-3","article-title":"Beta-cell activity and hepatic insulin extraction following dex-amethasone administration in healthy subjects","volume":"45","author":"Kautzky-Willer","year":"1996","journal-title":"Metabolism."},{"key":"10.4158\/EP.12.4.427_bb0250","first-page":"278","article-title":"Glucocorticoids antagonize insulin\u2019s antiproteolytic action on skeletal muscle in humans","volume":"79","author":"Louard","year":"1994","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.12.4.427_bb0255","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/0026-0495(93)90268-S","article-title":"Prednisolone enhances beta-cell function independently of ambient glycemic levels in type II diabetes","volume":"42","author":"Hosker","year":"1993","journal-title":"Metabolism."},{"key":"10.4158\/EP.12.4.427_bb0260","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0014-5793(03)00047-4","article-title":"Na+,K+-ATPase trafficking in skeletal muscle: insulin stimulates translocation of both alpha 1- and alpha 2-subunit isoforms","volume":"536","author":"Al-Khalili","year":"2003","journal-title":"FEBS Lett."},{"issue":"6 Pt 1","key":"10.4158\/EP.12.4.427_bb0265","doi-asserted-by":"crossref","first-page":"C1716","DOI":"10.1152\/ajpcell.1993.265.6.C1716","article-title":"Insulin increases the Na(+)-K(+)-ATPase alpha 2-subunit in the surface of rat skeletal muscle: morphological evidence","volume":"265","author":"Marette","year":"1993","journal-title":"Am J Physiol Cell Physiol."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20418142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20418142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/D3VXW5K3J1890AE6.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:46:10Z","timestamp":1761515170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20418142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S1530891X20418142"],"URL":"https:\/\/doi.org\/10.4158\/ep.12.4.427","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyrotoxic Periodic Paralysis in A Hispanic Man after the Administration Of Prednisone","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.12.4.427","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}